These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 15955672

  • 1. Co-trimoxazole and quinolone resistance in Escherichia coli isolated from urinary tract infections over the last 10 years.
    Karaca Y, Coplu N, Gozalan A, Oncul O, Citil BE, Esen B.
    Int J Antimicrob Agents; 2005 Jul; 26(1):75-7. PubMed ID: 15955672
    [Abstract] [Full Text] [Related]

  • 2. Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey.
    Arslan H, Azap OK, Ergönül O, Timurkaynak F, Urinary Tract Infection Study Group.
    J Antimicrob Chemother; 2005 Nov; 56(5):914-8. PubMed ID: 16174685
    [Abstract] [Full Text] [Related]

  • 3. Antibiotic resistance of urinary tract pathogens and evaluation of empirical treatment in Turkish children with urinary tract infections.
    Yüksel S, Oztürk B, Kavaz A, Ozçakar ZB, Acar B, Güriz H, Aysev D, Ekim M, Yalçinkaya F.
    Int J Antimicrob Agents; 2006 Nov; 28(5):413-6. PubMed ID: 17000085
    [Abstract] [Full Text] [Related]

  • 4. Increasing antimicrobial resistance in Escherichia coli isolates from community-acquired urinary tract infections during 1998-2003 in Manisa, Turkey.
    Kurutepe S, Surucuoglu S, Sezgin C, Gazi H, Gulay M, Ozbakkaloglu B.
    Jpn J Infect Dis; 2005 Jun; 58(3):159-61. PubMed ID: 15973007
    [Abstract] [Full Text] [Related]

  • 5. Antimicrobial susceptibility of clinical Escherichia coli isolates from uncomplicated cystitis in women over a 1-year period in Spain.
    Gobernado M, Valdés L, Alós JI, García-Rey C, Dal-Ré R, García-de-Lomas J, Spanish Surveillance Group for Urinary Pathogens.
    Rev Esp Quimioter; 2007 Mar; 20(1):68-76. PubMed ID: 17530038
    [Abstract] [Full Text] [Related]

  • 6. Nitrofurantoin: the return of an old friend in the wake of growing resistance.
    Kashanian J, Hakimian P, Blute M, Wong J, Khanna H, Wise G, Shabsigh R.
    BJU Int; 2008 Dec; 102(11):1634-7. PubMed ID: 18657135
    [Abstract] [Full Text] [Related]

  • 7. Emergence of fluoroquinolone resistance in outpatient urinary Escherichia coli isolates.
    Johnson L, Sabel A, Burman WJ, Everhart RM, Rome M, MacKenzie TD, Rozwadowski J, Mehler PS, Price CS.
    Am J Med; 2008 Oct; 121(10):876-84. PubMed ID: 18823859
    [Abstract] [Full Text] [Related]

  • 8. Trimethoprim/sulfamethoxazole resistance in urinary tract infections.
    Guneysel O, Onur O, Erdede M, Denizbasi A.
    J Emerg Med; 2009 May; 36(4):338-41. PubMed ID: 18325714
    [Abstract] [Full Text] [Related]

  • 9. Quinolone resistance in female outpatient urinary tract isolates of Escherichia coli: age-related differences.
    Gobernado M, Valdés L, Alós JI, Garcia-Rey C, Dal-Ré R, García-de-Lomas J, Spanish Surveillance Group for E. coli Urinary Pathogens.
    Rev Esp Quimioter; 2007 Jun; 20(2):206-10. PubMed ID: 17893757
    [Abstract] [Full Text] [Related]

  • 10. Risk factors for antibiotic-resistant Escherichia coli isolated from hospitalized patients with urinary tract infections: a prospective study.
    Sotto A, De Boever CM, Fabbro-Peray P, Gouby A, Sirot D, Jourdan J.
    J Clin Microbiol; 2001 Feb; 39(2):438-44. PubMed ID: 11158087
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Comparison of minimum inhibitory concentration values for fluoroquinolones against Escherichia coli causing urinary tract infection in both hospitalized patients and outpatients.
    Tayfour M, Yuce A, Yulug N.
    Saudi Med J; 2001 Oct; 22(10):848-51. PubMed ID: 11744939
    [Abstract] [Full Text] [Related]

  • 13. Extended-release ciprofloxacin (Cipro XR) for treatment of urinary tract infections.
    Talan DA, Naber KG, Palou J, Elkharrat D.
    Int J Antimicrob Agents; 2004 Mar; 23 Suppl 1():S54-66. PubMed ID: 15037329
    [Abstract] [Full Text] [Related]

  • 14. Susceptibility of antimicrobial-resistant urinary Escherichia coli isolates to fluoroquinolones and nitrofurantoin.
    Karlowsky JA, Thornsberry C, Jones ME, Sahm DF.
    Clin Infect Dis; 2003 Jan 15; 36(2):183-7. PubMed ID: 12522750
    [Abstract] [Full Text] [Related]

  • 15. Resistance to fluoroquinolones and treatment failure/short-term relapse of community-acquired urinary tract infections caused by Escherichia coli.
    Gagliotti C, Buttazzi R, Sforza S, Moro ML, Emilia-Romagna Antibiotic Resistance Study Group.
    J Infect; 2008 Sep 15; 57(3):179-84. PubMed ID: 18707763
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Antibiotic resistance among E. coli isolates from urinary tract infections (1999-2000): a multicenter study].
    Smaoui H, Mahjoubi F, Boutiba I, Jouaihia W, Thabet L, Znazen A, Kammoun A, Mezghanni S, Triki O, Hammami A, Ben Hassen A, Kechrid A, Ben Redjeb S.
    Tunis Med; 2003 Jun 15; 81(6):390-4. PubMed ID: 14534944
    [Abstract] [Full Text] [Related]

  • 19. Pharmacokinetic and pharmacodynamic aspects of antimicrobial agents for the treatment of uncomplicated urinary tract infections.
    Mazzei T, Cassetta MI, Fallani S, Arrigucci S, Novelli A.
    Int J Antimicrob Agents; 2006 Aug 15; 28 Suppl 1():S35-41. PubMed ID: 16829051
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.